D
DeepOMAP provides an AI-powered diagnostic platform that analyzes single-cell multi-omics datasets for cancer analysis. This platform assists oncologists by delivering early, accurate predictions of drug resistance and cancer progression pathways. The resulting insights enable faster turnaround times and support personalized treatment planning for improved patient outcomes.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- DeepOMAP provides an AI-powered diagnostic platform that analyzes single-cell multi-omics datasets for cancer analysis. This platform assists oncologists by delivering early, accurate predictions of drug resistance and cancer progression pathways. The resulting insights enable faster turnaround times and support personalized treatment planning for improved patient outcomes.